Timing of treatment of aneurysmal subarachnoid haemorrhage: are the goals set in international guidelines achievable?


Journal

Irish journal of medical science
ISSN: 1863-4362
Titre abrégé: Ir J Med Sci
Pays: Ireland
ID NLM: 7806864

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 14 01 2021
accepted: 02 02 2021
pubmed: 19 2 2021
medline: 28 1 2022
entrez: 18 2 2021
Statut: ppublish

Résumé

International guidelines emphasise the importance of securing ruptured cerebral aneurysms within 48-72 h of ictus. We assessed the timing of treatment of patients with aneurysmal subarachnoid haemorrhage (aSAH) referred to a national neurosurgical centre. Analysis of a prospective database of patients with aSAH admitted between 1st of February 2016 and 29th of February 2020 was performed. The timing to treatment was expressed in days and analysed in three ways: ictus to treatment, ictus to referral and referral to treatment. ORs with 95% CI were calculated for aneurysm treatment within 24, 48 and 72 h for good grade (WFSN 1-3) and poor grade (WFNS 4-5) cohorts separately. Of a total of 538 patients with aSAH, the aneurysm was secured in 312 (58%) within 24 h and in 398 (74%) within 48 h of ictus. Securing the aneurysm within 48 h of ictus was achieved in 89% (395/444) of patients who were referred within 24 h of ictus, but in only 3.2% (3/94) who were referred > 24 h after ictus. Poor grade patients (WFNS 4-5) were more likely than good grade patients (WFNS 1-3) to be referred to neurosurgery within 48 h of ictus (OR 22.87, 95% CI 3.14-166.49, p = 0.0020) and for their aneurysm to be secured within 48 h (OR 1.78, 95% CI 1.06-2.98, p = 0.0297) of ictus. Ictus to referral delay was highest in WFNS grade 1 patients. In centres with 7 day per week provision of interventional neuroradiology and vascular neurosurgery, the majority of patients with aSAH can be treated within the timeframes recommended by international guidelines and this applies to all grades of aSAH. However, delays still occur in a significant proportion of patients and this particularly applies to delays in presentation and diagnosis in good grade patients.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
International guidelines emphasise the importance of securing ruptured cerebral aneurysms within 48-72 h of ictus. We assessed the timing of treatment of patients with aneurysmal subarachnoid haemorrhage (aSAH) referred to a national neurosurgical centre.
MATERIALS AND METHODS METHODS
Analysis of a prospective database of patients with aSAH admitted between 1st of February 2016 and 29th of February 2020 was performed. The timing to treatment was expressed in days and analysed in three ways: ictus to treatment, ictus to referral and referral to treatment. ORs with 95% CI were calculated for aneurysm treatment within 24, 48 and 72 h for good grade (WFSN 1-3) and poor grade (WFNS 4-5) cohorts separately.
RESULTS RESULTS
Of a total of 538 patients with aSAH, the aneurysm was secured in 312 (58%) within 24 h and in 398 (74%) within 48 h of ictus. Securing the aneurysm within 48 h of ictus was achieved in 89% (395/444) of patients who were referred within 24 h of ictus, but in only 3.2% (3/94) who were referred > 24 h after ictus. Poor grade patients (WFNS 4-5) were more likely than good grade patients (WFNS 1-3) to be referred to neurosurgery within 48 h of ictus (OR 22.87, 95% CI 3.14-166.49, p = 0.0020) and for their aneurysm to be secured within 48 h (OR 1.78, 95% CI 1.06-2.98, p = 0.0297) of ictus. Ictus to referral delay was highest in WFNS grade 1 patients.
CONCLUSIONS CONCLUSIONS
In centres with 7 day per week provision of interventional neuroradiology and vascular neurosurgery, the majority of patients with aSAH can be treated within the timeframes recommended by international guidelines and this applies to all grades of aSAH. However, delays still occur in a significant proportion of patients and this particularly applies to delays in presentation and diagnosis in good grade patients.

Identifiants

pubmed: 33599919
doi: 10.1007/s11845-021-02542-1
pii: 10.1007/s11845-021-02542-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

401-406

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2021. Royal Academy of Medicine in Ireland.

Références

Sweeney K, Silver N, Javadpour M (2016) Subarachnoid haemorrhage (spontaneous aneurysmal). BMJ Clin Evid 2016:1–13
Nicholson P, Ohare A, Power S et al (2019) Decreasing incidence of subarachnoid hemorrhage. J Neurointerv Surg 11:320–322. https://doi.org/10.1136/neurintsurg-2018-014038
doi: 10.1136/neurintsurg-2018-014038 pubmed: 30314993
Steiner T, Juvela S, Unterberg A et al (2013) European stroke organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis 35:93–112. https://doi.org/10.1159/000346087
doi: 10.1159/000346087 pubmed: 23406828
R. Germans M, Hoogmoed J, Van Straaten HAS et al (2014) Time intervals from aneurysmal subarachnoid hemorrhage to treatment and factors contributing to delay. J Neurol 261:473–479. https://doi.org/10.1007/s00415-013-7218-2
doi: 10.1007/s00415-013-7218-2
Intercollegiate Stroke Working Party (2008) National clinical guideline for stroke - 3rd edition
Connolly ES, Rabinstein AA, Carhuapoma JR et al (2012) Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke 43:1711–1737. https://doi.org/10.1161/STR.0b013e3182587839
doi: 10.1161/STR.0b013e3182587839 pubmed: 22556195
Naidech AM, Janjua N, Kreiter KT et al (2005) Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage. Arch Neurol 62:410–416. https://doi.org/10.1001/archneur.62.3.410
doi: 10.1001/archneur.62.3.410 pubmed: 15767506
Ohkuma H, Tsurutani H, Suzuki S (2001) Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management. Stroke 32:1176–1180. https://doi.org/10.1161/01.STR.32.5.1176
doi: 10.1161/01.STR.32.5.1176 pubmed: 11340229
Siddiq F, Chaudhry SA, Tummala RP et al (2012) Factors and outcomes associated with early and delayed aneurysm treatment in subarachnoid hemorrhage patients in the United States. Neurosurgery 71:670–677. https://doi.org/10.1227/NEU.0b013e318261749b
doi: 10.1227/NEU.0b013e318261749b pubmed: 22653398
Tykocki T, Czyż M, Machaj M et al (2017) Comparison of the timing of intervention and treatment modality of poor-grade aneurysmal subarachnoid hemorrhage. Br J Neurosurg 31:430–433. https://doi.org/10.1080/02688697.2017.1319906
doi: 10.1080/02688697.2017.1319906 pubmed: 28436243
Wong GKC, Boet R, Ng SCP et al (2012) Ultra-early (within 24 hours) aneurysm treatment after subarachnoid hemorrhage. World Neurosurg 77:311–315. https://doi.org/10.1016/j.wneu.2011.09.025
doi: 10.1016/j.wneu.2011.09.025 pubmed: 22120257
Dorhout Mees SM, Molyneux AJ, Kerr RS et al (2012) Timing of aneurysm treatment after subarachnoid hemorrhage: relationship with delayed cerebral ischemia and poor outcome. Stroke 43:2126–2129. https://doi.org/10.1161/STROKEAHA.111.639690
doi: 10.1161/STROKEAHA.111.639690 pubmed: 22700527
De Gans K, Nieuwkamp DJ, Rinkel GJE, Algra A (2002) Timing of aneurysm surgery in subarachnoid hemorrhage: a systematic review of the literature. Neurosurgery 50:336–340. https://doi.org/10.1097/00006123-200202000-00018
doi: 10.1097/00006123-200202000-00018 pubmed: 11844269
Nieuwkamp DJ, De Gans K, Algra A et al (2005) Timing of aneurysm surgery in subarachnoid haemorrhage - an observational study in the Netherlands. Acta Neurochir (Wien) 147:815–820. https://doi.org/10.1007/s00701-005-0536-0
doi: 10.1007/s00701-005-0536-0
Mahaney KB, Todd MM, Torner JC (2011) Variation of patient characteristics, management, and outcome with timing of surgery for aneurysmal subarachnoid hemorrhage: Clinical article. J Neurosurg 114:1045–1053. https://doi.org/10.3171/2010.11.JNS10795
doi: 10.3171/2010.11.JNS10795 pubmed: 21250801
van Donkelaar CE, Bakker NA, Veeger NJGM et al (2015) Predictive factors for rebleeding after aneurysmal subarachnoid hemorrhage: rebleeding aneurysmal subarachnoid hemorrhage study. Stroke 46:2100–2106. https://doi.org/10.1161/STROKEAHA.115.010037
doi: 10.1161/STROKEAHA.115.010037 pubmed: 26069261
Gaberel T, Emery E (2015) Timing of surgical aneurysmal exclusion in SAH. J Neurosurg 122:1248. https://doi.org/10.3171/2011.2.JNS11277
doi: 10.3171/2011.2.JNS11277 pubmed: 25723299
Sorteberg A, Bredmose PP, Hansen AE, Sorteberg W (2019) The path from ictus to Neurosurgery: chronology and transport logistics of patients with aneurysmal subarachnoid haemorrhage in the South-Eastern Norway Health Region. Acta Neurochir (Wien) 161:1497–1506. https://doi.org/10.1007/s00701-019-03971-9
doi: 10.1007/s00701-019-03971-9
Dick R (2005) Managing the flow Cut Tool Eng 57:19–21. https://doi.org/10.1007/3-211-38158-9_1
doi: 10.1007/3-211-38158-9_1
Lamb JN, Crocker M, Tait MJ et al (2011) Delays in treating patients with good grade subarachnoid haemorrhage in London. Br J Neurosurg 25:243–248. https://doi.org/10.3109/02688697.2010.544787
doi: 10.3109/02688697.2010.544787 pubmed: 21545327
Oudshoorn SC, Rinkel GJE, Molyneux AJ et al (2014) Aneurysm treatment <24 versus 24–72 h after subarachnoid hemorrhage. Neurocrit Care 21:4–13. https://doi.org/10.1007/s12028-014-9969-8
doi: 10.1007/s12028-014-9969-8 pubmed: 24639201
Teo M, Teo M, Turner C et al (2017) What Factors determine treatment outcome in aneurysmal subarachnoid hemorrhage in the modern ERA? A post hoc STASH analysis. World Neurosurg 105:270–281. https://doi.org/10.1016/j.wneu.2017.05.005
doi: 10.1016/j.wneu.2017.05.005 pubmed: 28502692
Inagawa T (2011) Delayed diagnosis of aneurysmal subarachnoid hemorrhage in patients: a community-based study - Clinical article. J Neurosurg 115:707–714. https://doi.org/10.3171/2011.5.JNS102157
doi: 10.3171/2011.5.JNS102157 pubmed: 21682568

Auteurs

Abdurehman Choudhry (A)

National Neurosurgical Centre, Beaumont Hospital, Dublin, Ireland.
Royal College of Surgeons in Ireland, Dublin, Ireland.

Daniel Murray (D)

National Neurosurgical Centre, Beaumont Hospital, Dublin, Ireland.

Paula Corr (P)

National Neurosurgical Centre, Beaumont Hospital, Dublin, Ireland.

Deirdre Nolan (D)

National Neurosurgical Centre, Beaumont Hospital, Dublin, Ireland.

Deirdre Coffey (D)

National Neurosurgical Centre, Beaumont Hospital, Dublin, Ireland.

Stephen MacNally (S)

National Neurosurgical Centre, Beaumont Hospital, Dublin, Ireland.

Alan O'Hare (A)

Department of Neuroradiology, Beaumont Hospital, Dublin, Ireland.

Sarah Power (S)

Department of Neuroradiology, Beaumont Hospital, Dublin, Ireland.

Matthew Crockett (M)

Department of Neuroradiology, Beaumont Hospital, Dublin, Ireland.

John Thornton (J)

Department of Neuroradiology, Beaumont Hospital, Dublin, Ireland.
Royal College of Surgeons in Ireland, Dublin, Ireland.

Daniel Rawluk (D)

National Neurosurgical Centre, Beaumont Hospital, Dublin, Ireland.

Paul Brennan (P)

Department of Neuroradiology, Beaumont Hospital, Dublin, Ireland.
Royal College of Surgeons in Ireland, Dublin, Ireland.

Mohsen Javadpour (M)

National Neurosurgical Centre, Beaumont Hospital, Dublin, Ireland. mjavadpour@rcsi.ie.
Royal College of Surgeons in Ireland, Dublin, Ireland. mjavadpour@rcsi.ie.
Trinity College Dublin, Dublin, Ireland. mjavadpour@rcsi.ie.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH